---
title: "Describe the mechanism of action, and adverse effects, of pulmonary vasodilators that are administered via the inhalational route."
entityType: SAQ
exam: PEX
college: CICM
year: 2011
sitting: A
question: 14
passRate: 8
lo:
- "[[B2a]]"
- "[[2b]]"
- "[[2c]]"
- "[[2d]]"
- "[[2e]]"
EC_extraCredit:
- "Better answers included discussion of serious adverse effects such as methaemoglobinaemia, acute lung injury, systemic hypotension, rebound phenomena and heart failure."
EC_expectedDomains:
- "Accurate detail concerning the receptor and second messenger effects of drugs was expected."
- "The importance of V/Q matching and reduction in systemic effects via inhalational administration needed to be stated."
EC_errorsCommon:
- "Many candidates neglected to include oxygen which is also a drug with significant pulmonary vasodilating properties."
resources:
- "Basic and Clinical Pharmacology, Katzung, Chp 18, 19"
---